Disease-free survival (DFS) as a surrogate for overall survival (OS) in patients (pts) with HR+/HER2-early breast cancer (EBC): A correlation analysis.

被引：0
|
作者：
Untch, Michael
Perol, David
Mayer, Erica L.
Cortes, Javier
Nusch, Arnd
Cameron, David A.
Barrios, Carlos
Delea, Thomas E.
Salas, Tonatiuh Romero
Kalra, Manik
Gupta, Rhea
Pathak, Purnima
Fasching, Peter A.
机构：
[1] Helios Klinikum Berlin Buch, Interdisciplinary Breast Canc Ctr, Berlin, Germany
[2] Ctr Leon Berard, Dept Clin Res, Lyon, France
[3] Dana Farber Canc Inst, Boston, MA 02115 USA
[4] Int Breast Canc Ctr, Quiron Grp, Barcelona, Spain
[5] Univ Edinburgh, Edinburgh Canc Res Ctr, Edinburgh, Midlothian, Scotland
[6] Latin Amer Cooperat Oncol Grp LACOG, Porto Alegre, RS, Brazil
[7] Policy Anal Inc, Chestnut Hill, MA USA
[8] Novartis Pharmaceut, E Hanover, NJ USA
[9] Novartis Healthcare Pvt Ltd, Hyderabad, India
[10] Univ Hosp Erlangen, Dept Obstet & Gynecol, Erlangen, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
535
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Meta-analysis of disease free survival (DFS) as a surrogate for overall survival (OS) in localized renal cell carcinoma (RCC).
    Harshman, Lauren Christine
    Xie, Wanling
    Moreira, Raphael Brandao
    Gustavo, Ruiz
    Sweeney, Christopher
    Choueiri, Toni K.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [32] INFLUENCE OF METABOLIC SYNDROME ON OVERALL SURVIVAL (OS), DISEASE FREE SURVIVAL (DFS) AND INVASIVE FREE SURVIVAL (IFV) IN A COHORT OF PATIENTS TREATED FOR BREAST CANCER IN BRAZIL
    Antonini, Marcelo
    Guimaraes, Amanda Leal
    Richter, Fernanda Grace Bauk
    Ferraro, Odair
    Lopes, Reginaldo G. Coelho
    Real, Juliana M.
    Mattar, Andre
    CANCER RESEARCH, 2023, 83 (05)
  • [33] Establishing nomograms for predicting disease-free survival and overall survival in patients with breast cancer
    Zhou, Ling
    Bai, Lifen
    Zhu, Huiyin
    Guo, Chongyong
    Liu, Sheng
    Yin, Lu
    Sun, Jian
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2024, 44 (01)
  • [34] Disease-free survival (DFS) as a predictor of overall survival (OS) in completely resected early stage non-small cell lung cancer (NSCLC)
    West, H.
    Hu, X.
    Burke, T.
    Walker, M. S.
    Wang, Y.
    Samkari, A.
    ANNALS OF ONCOLOGY, 2022, 33 : S74 - S75
  • [35] The prediction models for postoperative overall survival and disease-free survival in patients with breast cancer
    Shigemizu, Daichi
    Iwase, Takuji
    Yoshimoto, Masataka
    Suzuki, Yasuyo
    Miya, Fuyuki
    Boroevich, Keith A.
    Katagiri, Toyomasa
    Zembutsu, Hitoshi
    Tsunoda, Tatsuhiko
    CANCER MEDICINE, 2017, 6 (07): : 1627 - 1638
  • [36] Racial/ethnic disparities in the survival of HR+/HER2-early breast cancer using the CPS plus EG scoring system
    Hanson, Kent A.
    Hoskins, Kent F.
    Ko, Naomi Y.
    Calip, Gregory S.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2022, 31 (01)
  • [37] Impact of ribociclib (RIB) dose modifications (mod) on overall survival (OS) in patients (pts) with HR+/HER2-advanced breast cancer (ABC) in MONALEESA(ML)-2.
    Hart, Lowell L.
    Bardia, Aditya
    Beck, Joseph Thaddeus
    Chan, Arlene
    Neven, Patrick
    Hamilton, Erika P.
    Sohn, Joohyuk
    Sonke, Gabe S.
    Bachelot, Thomas
    Spring, Laura
    Le Gac, Fabienne
    Hu, Huilin
    Gao, Ming
    De laurentiis, Michelino
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [38] High serum HER2 extracellular domain levels: correlation with a worse disease-free survival and overall survival in primary operable breast cancer patients
    Kong, Yanan
    Dai, Shuqin
    Xie, Xinhua
    Xiao, Xiangsheng
    Lv, Ning
    Guo, Jiaoli
    Li, Laisheng
    Jia, Weihua
    Zhang, Yin
    Liu, Wanli
    Wei, Weidong
    Xie, Xiaoming
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2012, 138 (02) : 275 - 284
  • [39] Mamographic density and disease-free survival in [HR+, HER2-] locally advanced breast cancer treated with neoadjuvant chemotherapy.
    Ingrid Rojas, Katerin
    Flores, Raymundo
    Flores, Claudio J.
    Pinto, Joseph A.
    Leonidas Gomez, Henry
    Castaneda, Carlos
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [40] High serum HER2 extracellular domain levels: correlation with a worse disease-free survival and overall survival in primary operable breast cancer patients
    Yanan Kong
    Shuqin Dai
    Xinhua Xie
    Xiangsheng Xiao
    Ning Lv
    Jiaoli Guo
    Laisheng Li
    Weihua Jia
    Yin Zhang
    Wanli Liu
    Weidong Wei
    Xiaoming Xie
    Journal of Cancer Research and Clinical Oncology, 2012, 138 : 275 - 284
12345